Crossmark

Enhancement of red blood cell transfusion compatibility using CRISPR‐mediated erythroblast gene editing

Crossref DOI link: https://doi.org/10.15252/emmm.201708454

Published Online: 2018-04-26

Published Print: 2018-06

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Hawksworth, Joseph

Satchwell, Timothy J

Meinders, Marjolein

Daniels, Deborah E

Regan, Fiona

Thornton, Nicole M

Wilson, Marieangela C

Dobbe, Johannes GG

Streekstra, Geert J

Trakarnsanga, Kongtana

Heesom, Kate J

Anstee, David J

Frayne, Jan

Toye, Ashley M https://orcid.org/0000-0003-4395-9396
Funding

Funding for this research was provided by:

NHS Blood and Transplant (WT15‐04)

NHS Blood and Transplant (WT15‐05)

National Institute for Health Research (NIHR‐BTRU‐2015‐10032)

Biotechnology and Biological Sciences Research Council (BB/L01386X/1 and EP/L016494/1)

Engineering and Physical Sciences Research Council (BB/L01386X/1 and EP/L016494/1)
License Information

Version of Record valid from 2018-04-26
More Information

Publication History

Received: 2017-09-04

Accepted: 2018-03-26

Published: 2018-04-26